Page last updated: 2024-08-25

bendamustine hydrochloride and Lymph Node Metastasis

bendamustine hydrochloride has been researched along with Lymph Node Metastasis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abarah, W; Bachy, E; Braun, T; Broussais, F; Cartron, G; Choufi, B; Clavert, A; Damaj, G; Fornecker, LM; Fruchart, C; Gac, AC; Garidi, R; Gaulard, P; Gyan, E; Herbaux, C; Houot, R; Jaccard, A; Joly, B; Le Bras, F; Maisonneuve, H; Malak, S; Marin, E; Martignoles, JA; Morschhauser, F; Parcelier, A; Pham, AD; Reboursiere, E; Rossi, C; Safar, V; Schirmer, L; Sibon, D; Tilly, H; Tournilhac, O; Tricot, S	1
Heinrich, G; Loibl, S; Müller, L; Murmann, C; Nekljudova, V; Schwedler, K; von Minckwitz, G; Warm, M	1

Studies

Abarah, W; Bachy, E; Braun, T; Broussais, F; Cartron, G; Choufi, B; Clavert, A; Damaj, G; Fornecker, LM; Fruchart, C; Gac, AC; Garidi, R; Gaulard, P; Gyan, E; Herbaux, C; Houot, R; Jaccard, A; Joly, B; Le Bras, F; Maisonneuve, H; Malak, S; Marin, E; Martignoles, JA; Morschhauser, F; Parcelier, A; Pham, AD; Reboursiere, E; Rossi, C; Safar, V; Schirmer, L; Sibon, D; Tilly, H; Tournilhac, O; Tricot, S

Heinrich, G; Loibl, S; Müller, L; Murmann, C; Nekljudova, V; Schwedler, K; von Minckwitz, G; Warm, M

Trials

1 trial(s) available for bendamustine hydrochloride and Lymph Node Metastasis

Article	Year
Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial. Cancer chemotherapy and pharmacology, 2009, Volume: 63, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Paclitaxel; Pleural Neoplasms; Survival Rate; Treatment Outcome	2009

Article

Year

Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.

Cancer chemotherapy and pharmacology, 2009, Volume: 63, Issue:5

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Paclitaxel; Pleural Neoplasms; Survival Rate; Treatment Outcome

2009

Other Studies

1 other study(ies) available for bendamustine hydrochloride and Lymph Node Metastasis

Article	Year
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study. Oncotarget, 2016, Dec-20, Volume: 7, Issue:51 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; France; Humans; Kaplan-Meier Estimate; Logistic Models; Lymphatic Metastasis; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome	2016

Article

Year

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.

Oncotarget, 2016, Dec-20, Volume: 7, Issue:51

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; France; Humans; Kaplan-Meier Estimate; Logistic Models; Lymphatic Metastasis; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome

2016